Communiqués DSS, Inc.

Actions

DSS

US26253C2017

Temps Différé Nyse Autres places de cotation 17:13:15 16/07/2024			Varia. 5j.	Varia. 1 janv.
1,59 ^USD	-1,24 %		-2,81 %	-33,81 %

14/05	DSS, Inc. annonce ses résultats pour le premier trimestre clos le 31 mars 2024	CI
17/04	Un juge nigérian se prononcera sur la libération sous caution du leader séparatiste le mois prochain	RE

Communiqués

Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !

Inscription 100% Gratuite

Impact Biomedical, Inc. Announces U.S. Patent Allowance of Laetose™ Technology Entitled "Low Glycemic Sugar Composition."	30/01	AQ
DSS, Inc. Chairman Chan Acquires 672,173 shares of DSS In Open Market	04/01	AQ
DSS, Inc. Announces Reverse Split as Part of NYSE American Compliance Plan	22/12	AQ
Premier Packaging, a Wholly-Owned Subsidiary of DSS, Inc., Secures Contract Extension with Major Retailer Worth Up to $15 Million over Four Years	28/11	AQ
Impact Biomedical Inc. Files Current Report on Form 8-K	15/11	AQ
DSS Inc. Wins Patent Dispute with Nichia Corporation	14/11	AQ
DSS, Inc. Subsidiary Files Current Report on Form 8-K Disclosing Reverse Split of Outstanding and Issued Common Stock and Conversion of Certain Holder’s Common Stock	08/11	AQ
DSS Inc. Receives Notice of Non-Compliance with NYSE American Trading Share Price Listing Rule	26/10/23	AQ
DSS, Inc. Announces Filing of Registration Statement on Form S-1 for Initial Public Offering of Impact Biomedical	23/10/23	AQ
DSS Inc. Issues Letter to Shareholders	12/10/23	AQ
DSS Inc. Expands DSS Wealth Management, Inc.'s Management Team for Ramp Up of Asset Management Subsidiary	06/09/23	AQ
DSS Inc. Announces Distribution Date of August 8, 2023 for Spinoff of Impact BioMedical Inc.	31/07/23	AQ
DSS, Inc.Ã¢€™s (NYSE American: DSS) Subsidiary Appoints New Chief Investment Officer to Aggressively Develop Mutual Fund Business for Eventual Spinoff	27/07/23	AQ
Revenue Increased 72% In Q1 2023 For Premier Packaging Corporation, A DSS, Inc. (NYSE: DSS) Wholly Owned Subsidiary	12/07/23	AQ
DSS Inc. Appoints Daniel Lew as Chief Investment Officer and Portfolio Manager for DSS Wealth, Inc.	05/07/23	AQ
DSS Inc. Announces Updated Shareholder of Record Date for Spinoff of Impact BioMedical Inc.	30/06/23	AQ
DSS Inc. Is Spinning Off Its Biotech Subsidiary After Signing A Major Licensing Agreement	27/06/23	AQ
DSS, Inc. Announces Record and Distribution Date for Impact Biomedical Spin-Off Special Dividend	26/06/23	AQ
DSS, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	16/05/23	AQ
Sub-Penny Momentum Watch (HBRM, SHRG, INQD, HCMC, SRMX)	02/05/23	AQ

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués DSS, Inc.

Actions

DSS

US26253C2017

Communiqués

Filtres